Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
about
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseRNA interference-based nanosystems for inflammatory bowel disease therapyRecent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseInhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.Colonic macrophage polarization in homeostasis, inflammation, and cancerHyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophagesPlant derived edible nanoparticles as a new therapeutic approach against diseases.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle.Curcumin-loaded redox response of self-assembled micelles for enhanced antitumor and anti-inflammation efficacy.Therapeutic gene delivery using bioreducible polymers.Nanotechnology in the treatment of inflammatory bowel diseases.Targeted delivery systems for biological therapies of inflammatory diseases.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.Nanomedicines for dysfunctional macrophage-associated diseases.Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerOral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.Nanotherapeutics for the treatment of inflammatory bowel disease.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa.
P2860
Q26777400-8890E053-A1F5-43A3-A70C-C5EA5B889260Q28071518-DB327CEB-90D1-46B3-9BE5-38F6293BE44EQ28073219-5317CE67-96E8-4146-B17E-C613F1C90250Q35119565-EBB595E0-6088-47C9-8556-9761426BF975Q36031099-52D3D67C-7921-45AE-A86B-6550FB050B35Q36201940-DD788514-85E1-4E3F-B6A7-4C900276A961Q36326103-740DB3F2-A5E8-48AF-B462-6BF2C6A02B74Q36414624-A9424E70-FC4D-4168-8636-B6E299E54776Q36869459-12695D95-A8D3-430D-B8C1-E1A3C0A672EFQ37012929-28934F02-D6FA-4678-B429-9542E83CBBF4Q37469872-1DE8405B-DBAD-4837-AF67-DDE2A4F92E8AQ37695146-6D6B3342-03B9-438E-BB98-79CF853F2C16Q37739981-DDB2D740-8A45-4D44-92F9-1F03D7C004B5Q38157750-8602C3D4-E096-48C5-9475-5BE77A918313Q38200842-FD3C4ADD-7E0D-4135-8AFC-34365AE1D89DQ38264691-37E196AB-C6F5-4261-B8C8-1F2984FA1C29Q38659150-C988D529-02C9-4720-A99B-623EE7C54D1BQ38834450-53DEF207-BCC7-4053-BA13-29DCD1F78A27Q39069052-83DBC621-BA95-477C-B051-7C49245352F8Q41468448-31784727-1CDF-49E1-B131-3C6F36EC5860Q42176588-0AD4A2AC-A1B7-4132-AA67-A2316D7D04BBQ46272530-35361ED4-4C6C-48C3-AC12-5D177DA55322Q47941914-7CA563D3-2077-45A7-97F2-02B2DFAC90D4Q47980720-F061D641-A050-451C-ABFD-ACB88E3981B8Q48020807-D43046AA-411E-483B-AAEF-93F637E90744Q51032601-4C311DD2-9DAD-4E46-8EB9-E95268F50F66
P2860
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mannosylated bioreducible nano ...... A interference for IBD therapy
@en
Mannosylated bioreducible nano ...... interference for IBD therapy.
@nl
type
label
Mannosylated bioreducible nano ...... A interference for IBD therapy
@en
Mannosylated bioreducible nano ...... interference for IBD therapy.
@nl
prefLabel
Mannosylated bioreducible nano ...... A interference for IBD therapy
@en
Mannosylated bioreducible nano ...... interference for IBD therapy.
@nl
P2093
P2860
P921
P1433
P1476
Mannosylated bioreducible nano ...... A interference for IBD therapy
@en
P2093
Didier Merlin
Hamed Laroui
Moiz A Charania
Saravanan Ayyadurai
Yuchen Zhang
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.06.008
P577
2013-06-29T00:00:00Z